Clinical Trial Update: Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating extracorporeal photopheresis in combination with mesenchymal stem cell infusion for graft-versus-host disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Extracorporeal Photopheresis
• Mesenchymal Stem Cell Infusion

Snippet

Sponsor: Molly Gallogly | Conditions: Graft Versus Host Disease | Phase 2 | Status: WITHDRAWN